Introduction
Cerebral cavernous malformations are hamartomous vascular lesions of the brain with an approximated prevalence of 0.2-0.9% -shown by necropsy and/or magnetic resonance imaging (MRI) studies.
1,2 They constitute nearly 10% of all vascular cerebral malformations. 3 The annual bleeding rate has been estimated to be between 0.2% and 3% per person per year of exposure. 2, [4] [5] [6] [7] Seizures are the most common clinical presentations in supratentorial cavernomas. Seizures are probably provoked because cavernomas have a tendency to microhemorrhage into adjacent brain tissue resulting in surrounding hemosiderin and gliosis, predisposing to epileptogenicity. 8 The literature documents several studies of patients with well established refractory epilepsy secondary to cerebral cavernomas where surgery of the cerebral lesions resulted in high rates of seizure freedom. [9] [10] [11] [12] However, there are no prospective randomized studies comparing surgical and conservative treatments for this type of patient. Therefore, it is still unknown if resection of the lesion is the optimal treatment for patients with cavernomas and new onset epilepsy, sporadic seizures, or non well established refractory epilepsy. The aim of this study was to compare clinical evolution in terms of seizure frequency of patients with cerebral cavernomas operated and non operated in order to obtain more information to the optimal management of these patients.
Materials and methods

Patients
We initially recruited retrospectively 54 patients with cerebral cavernomas and epilepsy from our clinical database.
Inclusion criteria in this study were: (a) at least, one epileptic seizure (before surgery in patients operated); (b) presence of supratentorial cavernoma, single or multiple, determined by computed tomography (CT) or MRI; and (c) at least, one year of follow up. All patients underwent a CT or MRI scan. Exclusion criteria were the presence of well established refractory epilepsy, defined by the recent proposal of ILAE for refractory epilepsy as failure of two adequate and well tolerated treatments in mono or bitherapy 13 before surgery. After being diagnosed of cavernoma, most patients were first sent to a neurosurgical service, so surgery was in most cases indicated by a neurosurgeon. Then, a lesionectomy or an extended lesionectomy was performed if the cavernoma was located in a non eloquent region. Surgery was undertaken on 19 patients because of seizures and 7 because of hemorrhages. None of the patients studied had a complete presurgical epilepsy evaluation. Only one patient was monitored through cortical mapping during surgery.
There were a number of reasons why some patients were only given medical treatment: because of the excellent control of their epilepsy, the location of the cavernoma in an eloquent area or because the patient declined surgery.
Patients were divided into two groups: (a) the surgical groupthese were the patients that underwent surgery and were treated by lesionectomy or extended lesionectomy and (b) the medically treated group.
Methods
A variety of clinical variables were analyzed, such as age and gender, age at epilepsy onset, duration of epilepsy, age at operation, kind and frequency of seizures, localization and size of cavernoma, presence of hemosiderin surrounding the cavernoma before and after surgery. The primary endpoint was the seizure frequency of the operated and non operated patients. We also looked at the possibility of treatment withdrawal, and the presence of surgical sequelae, and cavernoma bleeding during the follow up.
Statistics
Statistical analysis was undertaken with SPSS 12.0 for Windows (SPSS Inc., Chicago, IL, USA), and comparisons were performed using the Mann-Whitney U test.
Results
Demographic and clinical data
Out of the 54 patients recruited from our database, 11 were excluded from the analysis because of the presence of refractory epilepsy. Thus, the study was composed of 43 patients, aged between 23 and 74 years (mean, 47 years). Twenty-six patients (60.5%) were men, and 17 (39.5%), women. Mean age of seizure onset was 36 years (range 9-70 years). Localizations of the cavernomas in the brain were: 13 frontal, 13 temporal, 8 parietal, 8 multiple, and one patient had an occipital localization. The cavernoma was sized less than 2 cm in 19 patients (44.2%), between 2 and 6 cm in 23 (53.5%), and greater than 6 cm in one patient (2.3%). Hemosiderin deposits surrounding the cavernous angioma were detected by MRI in 30 cases (69.8%). Finally, 26 patients (60.5%) underwent surgery (lesionectomy in 22, and extended lesionectomy in 4). These 26 patients composed the surgical group, and the 17 non operated patients composed the medical conservative group. Comparison of principal demographic and clinical data of both groups is summarized in Table 1 . There were no significant differences in the baseline clinical characteristics between both groups.
Seizure outcome
At two years, 19 out of the 26 operated patients (73%) remained free of seizures, 4 (15%) had a seizure frequency lower than a seizure per month, and only one patient (4%) had more than one seizure per month. At five years, 15 patients of the surgical group remained for analysis. Of them, 11 (73.3%) were free of seizures, and the other 4 patients (26.7%) had less than one seizure a month. In the medical treatment group, 12 out of 17 patients were seizure free (70.6%). Only three patients of this group had a follow up less than 3 years. There were no significant differences in the incidence of seizures between the two groups (p = 0.2 and p = 0.3, respectively). Eleven patients of the surgical group were lost in the follow up because they were sent to their original hospitals. In seven patients surgery produced some neurological sequelae: dysesthesia, facial weakness, homonym hemianopsia, hemiparesis, mild dysphasia, and depression. Three out of the 4 patients who underwent extended lesionectomy (75%) were free of seizures at 2 and 5 years. Among the patients that underwent pure lesionectomy, 22 (72%) and 10 (66%) were free of seizures at 2 and 5 years follow up, respectively. In this group, antiepileptic drugs could be withdrawn from 9 of the 26 patients (34.6%) at two years, and from 5 of the 15 patients at five years (32.3%).
In the surgical group, seizure outcome was related neither to the occurrence of generalized tonic clonic seizures nor the number of seizures before surgery. However, patients who had epilepsy less than 18 months prior to surgery had a better outcome at 2 and at 5 years than the patients whose epilepsy was longer than 18 months previous to surgery: 15 of 16 patients (93%) at 2 years and 9 of 10 patients (90%) at 5 years were free of seizures while 5 of -(50%) at 2 years and 2 of 5 (40%) at 5 years were free of seizures. These were not statistically significantly different.
In the medical treatment group, 12 of the 17 patients remained seizure free (70.6%), one patient (5.9%) had an annual seizure, 3 (17.6%) had a seizure frequency less than one per month, and one patient (5.9%) had 2 or more seizures per month. Antiepileptic drugs were withdrawn from 3 patients (14, 2%) due to good control of seizures and pregnancy desire.
Comparing both groups, there were no significant differences in terms of seizure outcome either at 2 and 5 years (p = 0.2 and p = 0.3, respectively).
No patients in the medical group had neurological deterioration during the follow up. We did not observe worsening of the seizures in this group, but no patient had sequential MRI during the follow up.
Multiple cavernomatosis
Eight patients had multiples cavernomas. Four patients underwent surgery because of hemorrhage: three of them became seizure free (75%), and the other continues to have seizures with an annual frequency. The four patients who did not undergo surgery were seizure free.
Discussion
In our study, the outcome of patients -in terms of seizure frequency -did not show significant differences between the patients that underwent surgery, and those who were treated with conservative medical treatment (p = 0.2 and p = 0.3, respectively). We found similar results in patients with multiple cavernomas. However, the operated patients had more probability of successful withdrawal of antiepileptic treatment than the patients of the medically treated group (32-34% vs. 14%, respectively). Our results show (with some limitations listed below) that surgery in patients with new onset epilepsy, sporadic seizures, or non well established refractory epilepsy should be planned with caution, because seizure frequency would probably be the same had the patient received medical treatment instead.
Cavernomas are increasingly recognized as a cause of epilepsy, 14 and can produce refractory epilepsy. It is important to know precisely which is the best approximation to treat these patients. A detailed review of the literature on this issue reveals that surgery reaches high rates of seizure freedom in patients with cavernomas.
In most cases, seizure freedom is higher than 70%. 19, 10, 12, [15] [16] [17] [18] [19] [20] [21] The principal predictors of complete seizure freedom were: total resection of cavernomas, 11 short history of epilepsy, 11, 12, [17] [18] [19] [20] low number of seizures prior to surgery, 12, 19, 20 temporal localization of cavernoma, 9 absence of generalized tonic clonic seizures, 9,10 and small size of cavernoma. 9, 10 A recent review of the articles published in the past 25 years found the following characteristics correlated with favorable outcomes: extent of resection of the cavernoma and its surrounding hemosiderin ring, sporadic or single seizures, duration of epilepsy lesser than 1-2 years, and size of the cerebral cavernoma less than 1.5 cm. 22 In our study, the unique factor that was associated with better outcomes was short history of epilepsy, although, probably due to the low number of patients, we did not find significant differences. However, this study was not directly designed to study prognostic factors. Based on the literature data, it seems clear that surgical treatment is the best approach for patients with well established refractory epilepsy. However, there are no prospective randomized studies comparing medical and surgical treatment in patients with cavernomas and non refractory epilepsy. Our study, although retrospective, provides -to our knowledge -the largest comparative study between surgical or conservative treatment in patients with cerebral cavernomas. We only found in the literature a retrospective study of Noto et al. 19 in which the authors analyzed retrospectively 31 patients with cavernomas and epilepsy. Fifteen patients were treated medically, and 16 underwent surgery. The percentage of patients who became seizure free was significantly higher in the surgical group, so they concluded that surgical intervention may have greater benefits that medical treatment for these patients. Our study shows the same successful results of surgery, but we found a higher rate of seizure control in the medical group. However, we agree with Noto et al., that the number of anticonvulsivants can be reduced more with surgery than with medical treatment. In both our groups, patients with multiple cavernomas had an excellent control of seizures. Previous studies also showed high rates of seizure control (>70%) in patients with multiple cerebral cavernous malformations. 23, 24 Our study was limited by the non randomized group selection, the retrospective nature of the analysis, and the low number of patients, especially in the medical group, although this is, to our knowledge, the major series reported in the literature. In respect to the patients treated medically, another point that has to be taken into account is that the proper follow up of patients with epilepsy associated with cavernous angioma requires a prolonged period of time. Indeed, in our study, although one of the inclusion criteria was a minimal follow up of a year, the median age of the patients of the medical group was 50.2 years old, and their median age at the onset of epilepsy was 38, with only three patients in this group having a follow up below 3.
Conclusion
Although, at present, the surgical approach to cavernomas seems to better control seizures, this is not definitive. Surgery also has potentially serious risks. We believe that management of patients with cerebral cavernomas and epilepsy should be conducted according to the concepts of elective Epilepsy Surgery, with the standard epilepsy presurgical evaluation. A prospective and randomized study also needs be undertaken to clarify this uncertainty.
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